KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $87,600,000 | -33.9% | 6,000,000 | -14.3% | 1.24% | -52.5% |
| Q2 2020 | $132,580,000 | -1.4% | 7,000,000 | 0.0% | 2.62% | -42.3% |
| Q1 2020 | $134,470,000 | +18.9% | 7,000,000 | +18.6% | 4.54% | +36.7% |
| Q4 2019 | $113,103,000 | +94.3% | 5,900,000 | -2.5% | 3.32% | +36.8% |
| Q3 2019 | $58,201,000 | +673.5% | 6,050,000 | +979.1% | 2.43% | +576.3% |
| Q1 2018 | $7,524,000 | – | 560,658 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |